Cinctive Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$672K	–	517
2021 Q3	$672K	Buy	+6,000	New	+$672K	0.03%	408